The invention belongs to the technical field of
biology, and particularly relates to an anti-hu-OX40
antigen nano
antibody which is a
monoclonal nano
antibody and comprises a
heavy chain variable region; the
heavy chain variable region comprises a CDR1 region, a CDR2 region and a CDR3 region, wherein the CDR1 region, the CDR2 region and the CDR3 region respectively comprise any one of
amino acid sequences as shown in SEQ ID NO: 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38 and 39 or a
homologous sequence with at least 80%
sequence identity with any one of the
amino acid sequences as shown in SEQ ID NO: 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38 and 39. According to the invention, 9 specific full-human anti-human OX40 nano antibodies A1, B7, C4, C7, C10, D1, D2, D7 and D12 are screened and optimized from a constructed large-capacity full-synthetic human
phage antibody library, so that the immunostimulation of T
effector cells can be enhanced, the
secretion of
cell factors can be promoted, and a remarkable
tumor inhibition effect is shown in a
mouse tumor model.